Abstract 13165: Dapagliflozin for Reduction of Blood Pressure in Diabetic Patients Inadequately Controlled With Combination Antihypertensive Regimen

Hypertension is a frequent comorbidity of type 2 diabetes (T2D); dual antihypertensive agents (ACEi or ARB plus a second agent) may not provide adequate control. Dapagliflozin (DAPA), a sodium gluc...